Welcome to Gentronix

Gentronix provides services and solutions to help organisations optimise the development of drugs and other chemicals, by testing for genotoxicity,  across a wide range of chemistry driven industries.

Gentronix offers classical Ames and Micronucleus genotoxicity assays plus GreenScreen®HC and BlueScreen™HC; our novel, patented systems that detect all known classes of genotoxin. Gentronix can provide assays and advice on follow-up strategies for mechanism elucidation to help chemists modify compounds to eliminate genotoxicity early in product discovery and development.

Gentronix is GLP compliant and offers regulatory assays to OECD and other test guidelines.

Latest News

Board Changes at Gentronix Ltd.

The Genotoxicity specialist Gentronix is pleased to announce that Dr. Matt Tate has joined the Gentronix Ltd Board as Technical…